An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Müller, R.-U., Lianne Messchendorp, A., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Kidneys, 11 (1). pp. 37-39. ISSN 2307-1257

Metadata

Authors/Creators:
  • Müller, R.-U.
  • Lianne Messchendorp, A.
  • Birn, H.
  • Capasso, G.
  • Cornec-Le Gall, E.
  • Devuyst, O.
  • Eerde, A.V.
  • Guirchoun, P.
  • Harris, T.
  • Hoorn, E.J.
  • Knoers, N.V.A.M.
  • Korst, U.
  • Mekahli, D.
  • Le Meur, Y.
  • Nijenhuis, T.
  • Ong, A.C.M. ORCID logo https://orcid.org/0000-0002-7211-5400
  • Sayer, J.A.
  • Schaefer, F.
  • Servais, A.
  • Tesar, V.
  • Torra, R.
  • Walsh, S.B.
  • Gansevoort, R.T.
Copyright, Publisher and Additional Information: © 2022. This work is licensed under a Creative Commons Attribution 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
Dates:
  • Published (online): 24 May 2022
  • Published: 24 May 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 16 Sep 2022 15:52
Last Modified: 16 Sep 2022 15:52
Status: Published
Publisher: Publishing House Zaslavsky
Refereed: Yes
Identification Number: https://doi.org/10.22141/2307-1257.11.1.2022.357

Share / Export

Statistics